On this page

What is HIV?
How Widespread is HIV?
Incubation Period
Symptoms in Men and Women
How is HIV Transmitted?
Diagnosis
Treatment and Care
Living with HIV: Outlook and Life Expectancy
Frequently Asked Questions
Sources and Bibliography

What is HIV?

HIV (Human Immunodeficiency Virus) is a virus that damages the cells of the immune system, gradually weakening the body’s ability to fight off infections and diseases. HIV specifically attacks and destroys CD4+ T-helper lymphocytes, which are essential cells for coordinating the immune response. As these cells are progressively depleted, the immune system becomes less and less able to defend the body against pathogens it would normally control with ease.

AIDS (Acquired Immune Deficiency Syndrome) is the term used to describe a group of potentially life-threatening infections and cancers that occur once the immune system has been severely damaged by HIV. AIDS represents the final and most advanced stage of untreated or poorly controlled HIV infection, not a separate disease in itself.

With early diagnosis and effective treatment (antiretroviral therapy, or ART), most people living with HIV today will never develop any AIDS-related illness and can expect to live a largely normal life, with a life expectancy close to that of the general population. A person on effective treatment whose viral load is undetectable cannot transmit the virus to others, a concept known worldwide as U=U (Undetectable = Untransmittable).

HIV is transmitted through direct contact with blood, semen, vaginal secretions, or breast milk from a person living with the virus. For transmission to occur, these fluids must come into contact with the bloodstream or mucous membranes of another person, for example through unprotected sexual intercourse, sharing needles, or from mother to child during pregnancy, childbirth, or breastfeeding. HIV is not transmitted through everyday contact such as hugging, shaking hands, or sharing household objects.

The early symptoms of HIV infection, known as acute retroviral syndrome, typically appear 2 to 4 weeks after exposure and can include fever, sore throat, skin rash, muscle aches, and swollen lymph nodes. These symptoms result from the immune system’s initial response to the virus, are nonspecific, and are not always present. After this initial phase, the infection can remain silent, without any noticeable symptoms, for many years.

Diagnosis relies on specific blood tests, such as the fourth-generation combination test, which can detect the infection within just a few weeks of exposure.

Although there is currently no definitive cure or approved vaccine, modern antiretroviral therapies (ART) can effectively suppress the virus, prevent progression to AIDS, and dramatically reduce the risk of transmission to others.

How Widespread is HIV?

The first cases of AIDS were reported in 1981, although it is now believed that HIV infection had already been circulating, unrecognized, for many years before that. HIV infection, and the AIDS it can lead to if untreated, remains one of the leading causes of illness and death worldwide, affecting millions of people across all age groups. In the United States, AIDS was the sixth leading cause of death among young people aged 15 to 24 in 1991, a stark reminder of how devastating the epidemic once was before effective treatments existed.

Since the widespread introduction of antiretroviral therapy (ART) in the mid-1990s, there has been a substantial decline in both new infections and AIDS-related deaths in many countries. This positive trend continues today, with life expectancy for people diagnosed early with HIV now approaching that of the general population when effective treatment is available.

Today, sexual transmission is the primary route of HIV spread in most countries, whereas in earlier decades the infection was frequently associated with the sharing of contaminated needles among people who inject drugs.

According to data from the World Health Organization (WHO), HIV has caused more than 42 million deaths worldwide since the beginning of the epidemic. By the end of 2023, an estimated 39 million people were living with HIV globally, roughly two-thirds of them in Africa.

Despite these sobering numbers, significant progress has been made: between 2000 and 2016, new HIV infections fell by 39%, and HIV-related deaths dropped by about a third. Continued global investment in testing, prevention, and treatment programs has helped sustain this downward trend in many regions.

Today, thanks to major advances in medical science, HIV is no longer considered a fatal disease for people who have access to treatment. Instead, it is managed as a chronic condition that requires careful medical follow-up and consistent treatment adherence to ensure a good quality of life.

Incubation Period

The incubation period of HIV, meaning the time between infection and the appearance of the first symptoms, generally lasts between 2 and 4 weeks.

During this early phase, the virus replicates very rapidly, and the amount of virus circulating in the blood (viral load) rises sharply, making the infected person highly contagious even before they may be aware of it. However, this incubation period is often completely asymptomatic, which means many people have no idea they have contracted the virus. This is precisely why HIV testing after any potentially risky behavior is so important for early diagnosis, timely treatment, and prevention of further transmission.

Symptoms in Men and Women

HIV infection typically progresses through several distinct clinical phases:

acute infection,
clinical latency (a chronic, often symptom-free phase),
and, if left untreated, progression to AIDS.

It is worth noting that symptoms of HIV are generally similar in men and women, since the disease process affects the immune system in the same way regardless of sex. However, women living with HIV may also experience specific gynecological symptoms, such as more frequent or severe vaginal yeast infections, changes in menstrual cycles, or an increased risk of cervical abnormalities, which is why regular gynecological screening, including Pap smears, is recommended as part of routine HIV care for women.

Acute Infection

After exposure to the virus, some individuals develop acute infection within 2 to 4 weeks, presenting with flu-like symptoms that generally last 1 to 2 weeks. Not everyone experiences noticeable symptoms during this stage, but when present, they can include:

fever
lymphadenopathy (swelling of the lymph nodes)
pharyngitis (sore throat)
skin rash (maculopapular rash)
myalgia (muscle pain)
fatigue and general malaise

Less commonly, symptoms may also include nausea and vomiting, headache, unintentional weight loss, or neurological symptoms resembling meningitis (very few cases worldwide have even been linked to facial paralysis during acute infection).

During this acute phase, the viral load in the blood is extremely high, which means the risk of transmitting the virus to others is at its peak, even though the infected person may simply feel like they have a common flu or cold.

Clinical Latency

The next stage, known as clinical latency, can last for many years, especially in people who are receiving antiretroviral therapy. During this phase, the virus continues to replicate at low levels, but the person typically experiences no symptoms at all and can feel completely healthy. Without any treatment, progression from this latent stage to AIDS can take 10 years or longer, although the exact timeline varies considerably from person to person.

Adolescents and adults who contract HIV often never experience clearly noticeable symptoms, or they may mistake the early signs for a common cold or flu. During this period, particularly during the acute phase of infection when viral load is highest, individuals can unknowingly transmit the virus to others without realizing they have contracted it themselves. This underscores the critical importance of early diagnosis through specific testing after any risky behavior, rather than waiting for symptoms to appear.

AIDS

AIDS, the advanced stage of HIV infection, develops when the immune system has been severely damaged, typically reflected by a CD4 lymphocyte count below 200 cells/μL. Symptoms at this stage depend on which opportunistic infections or cancers develop, and can include:

pneumonia caused by Pneumocystis jirovecii
esophageal candidiasis (a fungal infection of the esophagus)
cerebral toxoplasmosis
Kaposi’s sarcoma, a type of cancer affecting blood vessel walls
lymphomas, cancers of the lymphatic system

Thanks to advances in medicine, HIV infection today, even when it has progressed toward AIDS, can often be managed effectively as a chronic condition once diagnosed and treated, though earlier diagnosis always leads to better long-term outcomes and a lower risk of permanent organ damage.

Symptoms in Newborns

Newborns with HIV often show no obvious signs at birth, but without treatment, they can develop symptoms within the first months of life. Among the most common warning signs are poor growth or failure to thrive, recurrent infections such as oral thrush or bacterial pneumonia, enlargement of the lymph nodes, liver, or spleen, and in some cases neurological problems affecting development.

In the absence of therapy, infants are particularly vulnerable to opportunistic infections, such as pneumonia caused by Pneumocystis jirovecii. In countries with high HIV prevalence and limited healthcare resources, tuberculosis remains a frequent and serious cause of complications and mortality among HIV-positive children.

However, thanks to routine newborn screening programs and early initiation of antiretroviral therapy, it is possible to prevent the vast majority of these symptoms and allow children born with HIV to enjoy a quality of life comparable to that of their HIV-negative peers.

How is HIV Transmitted?

A Key Premise

People living with HIV who are on effective antiretroviral treatment, with an undetectable viral load, do not transmit the virus to others. This concept, known as U=U (Undetectable = Untransmittable), represents one of the most important breakthroughs in the modern management of HIV, both for individual health and for public health efforts to curb the epidemic.

Mechanisms of HIV Transmission

HIV is transmitted through direct contact with blood, semen, vaginal secretions, or breast milk from a person living with the virus. The main situations that carry a risk of transmission include:

unprotected vaginal or anal intercourse (the risk is higher for anal intercourse, and increases further in the presence of other sexually transmitted infections such as syphilis, genital herpes, chlamydia, gonorrhea, and bacterial vaginosis, since these conditions can cause small breaks in mucosal tissue that make transmission easier)
sharing contaminated needles, syringes, or other unsterilized equipment used for injecting drugs, tattoos, or piercings
blood transfusions or organ transplants, although this risk is now nearly eliminated in countries with rigorous blood-screening and safety standards

Transmission to Newborns

In infants, the virus can be transmitted:

during pregnancy (intrauterine transmission across the placenta.)
during childbirth, through exposure to maternal blood and fluids during delivery.
through breastfeeding, if the mother is not receiving antiretroviral therapy. In countries where safe infant formula is accessible and affordable, formula feeding is generally recommended for HIV-positive mothers to eliminate this risk entirely.

With appropriate antiretroviral treatment during pregnancy, delivery, and postpartum, the risk of mother-to-child transmission can be reduced to less than 1%, making this one of the great public health success stories in HIV prevention.

Prevention Strategies

Correct and consistent condom use is highly effective at preventing sexual transmission of HIV.
Pre-exposure prophylaxis (PrEP) is recommended for individuals at higher risk of HIV exposure and significantly reduces the likelihood of infection when taken as prescribed.
Post-exposure prophylaxis (PEP), if started within 72 hours of a potential exposure, can prevent the virus from establishing infection in the body.

Further details on both PrEP and PEP are provided later in this article, in the treatment section.

Other Transmission Routes

In very rare cases, the virus can be transmitted through open wounds that come into direct contact with infected blood.
In healthcare settings, accidental exposures, such as needlestick injuries with contaminated equipment, represent a real but low risk, which can be further minimized through strict safety protocols, protective equipment, and prompt post-exposure prophylaxis when indicated.

No Risk of Transmission

HIV is not transmitted through:

hugging, shaking hands, or other casual physical contact
sharing bathrooms, plates, utensils, or drinking glasses
social kissing (a brief kiss on the cheek or closed-mouth kiss)
saliva, tears, or sweat, unless visibly contaminated with blood
mosquito bites or bites from other insects

Sexual Transmission

HIV is transmitted through specific body fluids, including:

blood
semen
pre-ejaculatory fluid (there is some debate among experts about the exact level of risk this fluid carries)
vaginal secretions
and breast milk

Saliva, on the other hand, does not contain significant amounts of the virus, unless it is visibly mixed with blood.

All mucous membranes of the body represent potential entry points for the virus, including:

the glans and inner foreskin tissue of the penis
the vagina
the conjunctiva of the eye
the interior lining of the anus
the nostrils and interior of the nose
the mouth

From a broad, general perspective, sexual activities can be roughly categorized by risk level:

mutual masturbation is considered a safe sexual practice
condom-protected intercourse and kissing are considered relatively safe

The risk is highest for unprotected vaginal or anal intercourse, particularly for the receptive partner (the person being penetrated), since the mucous membranes involved are more easily exposed to infected fluids and more prone to microscopic tears.

Correct and consistent condom use substantially reduces the risk of transmission, but if a condom breaks during intercourse, it is important to stop immediately and consult a doctor as soon as possible to discuss whether post-exposure prophylaxis (PEP) is appropriate.

No Risk

Everyday personal, family, and social contact (hugging, kissing on the cheek, shaking hands, sharing glasses and utensils, sharing a bed or towel, sharing a comb or hairbrush, sneezing or coughing, contact games at school, and similar activities). Sharing toothbrushes and razors should still be avoided, however, due to the potential for blood contact.
Contact with sweat.
Contact with tears.
Kissing (low risk only in cases of gum disease, periodontal disease, or active bleeding wounds in the mouth).
Licking a partner’s body, excluding intimate areas, for both partners involved.
Male masturbation, for both the active and passive partner (ejaculation onto the hand or other non-intimate areas of the body carries no risk, since intact skin is an effective protective barrier. It is, of course, important to wash hands or any skin in contact with semen thoroughly before touching intimate areas or other mucous membranes such as the mouth or eyes. If the skin on the hands is not fully intact, contact with semen carries a low level of risk.)
Female masturbation, from the perspective of both partners (if the skin on the hands is not fully intact, there is a low level of risk).

Low Risk

Receptive fellatio (placing the penis in a partner’s mouth): risk arises only if there are open, bleeding wounds in the partner’s mouth.
Insertive fellatio (performing oral sex on a partner) without ejaculation in the mouth. Some infectious disease specialists consider the risk in this scenario to be essentially zero.
Receptive cunnilingus (receiving oral stimulation of the vagina): risk arises only if there are open, bleeding wounds in the partner’s mouth.
Performing cunnilingus (oral stimulation of a partner’s vagina): risk is higher for the person performing this act, and increases significantly during menstruation or in the presence of gum disease, cuts, or sores in the mouth.
Anilingus (oral-anal contact): risk is nil to very low for the receiving partner (although some sources note the risk could become non-negligible under certain specific circumstances), and low to very low for the active partner, depending on the source consulted. Naturally, the risk changes accordingly if there is oral or anal bleeding present.

High Risk

Vaginal intercourse, from the male partner’s perspective (risk increases significantly if the female partner is menstruating).
Ejaculation onto the face, for the partner who comes into contact with the semen (particularly if seminal fluid contacts the mucous membranes of the mouth or eyes, and especially in the presence of contributing factors like microscopic abrasions).
Insertive fellatio (performing oral sex on a partner) with ejaculation in the mouth.

Very High Risk

Vaginal intercourse, from the female partner’s perspective, since the risk is increased by the presence of semen in the vagina for many hours or even days afterward.
Anal intercourse, for both partners (the risk for the receptive partner is significantly higher than for the insertive partner).

It is also worth remembering that, beyond HIV, unprotected sexual contact and certain other types of physical contact can transmit a range of other infections, so condom use and regular STI screening remain important regardless of HIV status.

Sex with HIV-Positive Partners on Treatment

It has been conclusively demonstrated that a person living with HIV who is on effective antiretroviral therapy, with an undetectable viral load maintained for at least six months, is not infectious to sexual partners (when treatment is followed correctly, an increase in viral load is rare and is usually linked to specific factors such as drug resistance or a concurrent illness).

This principle is strongly supported by robust evidence in the scientific literature, most notably from the landmark HPTN 052, PARTNER, and Opposites Attract studies, and is now widely accepted and actively promoted by the world’s leading health authorities, including the American CDC and NIH, and the British NHS.

This important finding is summarized by the well-known phrase Undetectable = Untransmittable (U=U), which reflects the concept often described as “treatment as prevention”: consistent, regular use of antiretroviral medication effectively eliminates the risk of sexual transmission in serodiscordant couples (meaning couples in which only one partner is HIV-positive).

This should not, however, be understood as a green light to have unprotected sex with an unknown or new partner based on the assumption that “they are probably on treatment if they are HIV-positive”. There are several important reasons why this assumption is risky:

first and foremost, not everyone living with HIV is aware of their status, and therefore is not receiving any treatment at all (in fact, the majority of new infections are transmitted by people who do not know they are HIV-positive);
even among those who are aware of their status, not everyone begins treatment immediately;
achieving an undetectable viral load can take up to six months of consistent therapy (although in many patients the viral load drops much faster);
other sexually transmitted infections still pose a real risk, regardless of HIV status;
finally, there is no way to know whether a new or unfamiliar partner who is HIV-positive is actually taking their medication every day, exactly as prescribed.

In any case, the decision to have unprotected sex should always be a conscious, informed, and mutually agreed-upon choice between partners who know and trust each other’s status. None of the above should be read as justification for risky sexual behavior, such as unprotected sex with casual or unknown partners. Not everyone living with HIV knows their status, not everyone adheres properly to treatment, and not everyone has achieved an undetectable viral load. In addition, condoms remain essential for preventing other sexually transmitted infections, such as gonorrhea, syphilis, and herpes, which are not affected by HIV treatment status.

These research findings are instead most relevant and useful in specific contexts, such as:

serodiscordant couples, meaning couples formed by one HIV-negative and one HIV-positive partner, for example when the couple wishes to plan a pregnancy in the context of HIV;
a monogamous serodiscordant couple, whether heterosexual or same-sex, who make an informed, joint decision to have sex without condoms;
a serodiscordant couple who chooses to continue using condoms anyway, for extra peace of mind in case of an accident, such as a condom breaking during intercourse.

Finally, during pregnancy and breastfeeding, the risk of transmission to the newborn is extremely low when the mother is on effective antiretroviral therapy, though it still requires ongoing, close medical monitoring throughout pregnancy and the postpartum period.

It is important to understand that even when viral load becomes undetectable, HIV is never fully eliminated from the body. The virus persists in an inactive form within certain reservoir cells and is capable of reactivating and replicating rapidly if antiretroviral therapy is ever stopped, which is why lifelong treatment adherence remains essential.

Diagnosis

Timely diagnosis of HIV infection is essential, not only for the health of the individual, who can begin treatment immediately and prevent disease progression, but also for public health, since it dramatically reduces the chances of unknowingly transmitting the virus to others. The only reliable way to determine HIV status is through specific testing, since the absence of symptoms never rules out the presence of the virus.

Fourth-Generation Screening Tests

The current standard diagnostic protocol relies on fourth-generation combination tests (ELISA or CMIA assays). These tests are extremely sensitive and simultaneously screen for two markers:

Anti-HIV-1 and anti-HIV-2 antibodies: proteins produced by the immune system in response to the virus.
p24 antigen: a viral protein that appears in the blood well before antibodies develop, significantly shortening the so-called “window period”, the time between infection and when a test can reliably detect it.

Confirmatory and Monitoring Tests

If a screening test comes back positive, the diagnosis must be confirmed with a second-level test, typically a Western Blot or an Immunoblot assay, which identifies antibodies against several distinct viral proteins and provides a definitive confirmation. Once the diagnosis is confirmed, additional tests are performed to assess the stage of infection and guide treatment planning:

Viral load (HIV-RNA): measures the amount of virus circulating in the blood, an important indicator of disease activity and treatment effectiveness.
CD4 lymphocyte count: assesses the current health and strength of the immune system.
Resistance testing: essential for identifying which antiretroviral medications are likely to be most effective for that particular patient, based on the genetic characteristics of their specific viral strain.

Self-Tests and Rapid Tests

For those who prefer greater privacy or a faster result, several options are available. HIV self-tests can be purchased at pharmacies without a prescription (for adults) and performed conveniently at home using a small capillary blood sample or oral fluid swab. It is important to remember that these tests often have a longer window period, generally around 3 months, and any positive result always requires official confirmation at a specialized testing center.

Where to Get Tested

HIV testing can be performed at public diagnostic centers, including hospitals, community health services, and dedicated STI clinics. In many countries, testing may be available free of charge and/or anonymously, and a doctor’s prescription may not be required at public or community testing facilities. Availability, cost, and access requirements vary by country and healthcare system.

Treatment and Care

Today, HIV infection is no longer a death sentence but a chronic condition that can be managed extremely effectively with modern medicine. The primary goal of treatment is virologic suppression, meaning reducing the amount of virus in the blood to a level so low that it becomes “undetectable” by standard laboratory tests. This allows the immune system to recover and regenerate, and it completely eliminates the risk of sexual transmission (U=U).

Antiretroviral Therapy (ART)

Treatment is based on a combination of several antiretroviral medications that work by blocking the virus at different stages of its replication cycle. Current clinical guidelines recommend starting therapy as soon as possible after diagnosis (an approach known as “Test and Treat”), regardless of the patient’s current CD4 lymphocyte count.

Modern treatment options include:

Single Tablet Regimens (STR): most patients today take just one pill per day, containing a combination of two or three active medications. This has dramatically simplified treatment adherence and significantly reduced the side effects that were common with older, more complex drug regimens.
Long-acting therapies: these represent the newest and most innovative frontier in HIV treatment. They consist of intramuscular injections administered by healthcare providers, typically every two months. This option is generally reserved for patients who are already clinically stable with a fully suppressed viral load, and it eliminates the need for a daily pill altogether, which can be a meaningful improvement in quality of life for many patients.

Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP)

In addition to treating people who already have HIV, modern medicine also offers powerful pharmacological tools to prevent new infections:

PrEP (Pre-Exposure Prophylaxis): involves HIV-negative individuals at high risk of exposure taking antiretroviral medication on an ongoing basis. When taken consistently and correctly, PrEP is close to 100% effective at preventing HIV infection.
PEP (Post-Exposure Prophylaxis): an emergency treatment that must be started as soon as possible, and always within 72 hours, following an accidental exposure to the virus (such as a condom breaking or a needlestick injury with contaminated equipment). The course lasts 28 days and can prevent the virus from establishing a permanent infection in the body if started promptly.

Lifestyle and Overall Well-Being

Because people living with HIV today generally have a life expectancy comparable to that of the general population, clinical management has increasingly shifted its focus toward preventing the chronic health conditions associated with aging. Lifestyle plays a crucial role in this broader approach to long-term health:

Cardiovascular health: HIV itself, along with certain antiretroviral medications, can slightly increase the risk of heart disease over time. It is important for people living with HIV to have their blood pressure and cholesterol regularly monitored and to avoid smoking.
Diet and physical activity: a balanced diet and regular exercise help prevent osteoporosis and metabolic complications, such as changes in blood sugar or fat distribution, which can be associated with both the virus itself and some medications.
Psychological support: coming to terms with an HIV diagnosis can be emotionally challenging. Support from mental health specialists or peer support groups is often an integral part of comprehensive HIV care, helping patients maintain a full and satisfying social and emotional life.

Despite how effective modern medications are, it is essential never to stop antiretroviral therapy without medical supervision. The virus is capable of “hiding” within certain cellular reservoirs in the body and would quickly begin replicating again if treatment were interrupted, even after years of successful viral suppression.

Living with HIV: Outlook and Life Expectancy

One of the most important messages for anyone newly diagnosed with HIV, or supporting a loved one through diagnosis, is that the outlook today is fundamentally different from what it was in the early decades of the epidemic. Large international cohort studies, such as the analysis published in The Lancet HIV tracking survival among patients starting antiretroviral therapy between 1996 and 2013, have shown a steady and substantial improvement in life expectancy over time, particularly for those who begin treatment early, before significant immune damage has occurred.

People diagnosed with HIV today, who start treatment promptly and take their medication consistently, can generally expect to live a normal lifespan, pursue careers, build families, and maintain fulfilling relationships. Many go on to have HIV-negative children through appropriate medical guidance during conception, pregnancy, and delivery. The combination of daily oral therapy or long-acting injections, regular medical follow-up, and a healthy lifestyle allows most people with HIV to lead lives that are, in almost every practical sense, indistinguishable from those of people without the virus.

Stigma, unfortunately, remains one of the most significant ongoing challenges for people living with HIV, often causing more day-to-day distress than the medical aspects of the condition itself. Public education, accurate information about transmission risks (or lack thereof) in everyday situations, and continued normalization of HIV as a manageable chronic illness are all essential steps toward reducing this stigma and supporting the well-being of people living with the virus.

Frequently Asked Questions

What is the difference between HIV and AIDS?

HIV (Human Immunodeficiency Virus) is a virus that attacks and progressively destroys key cells of the human immune system. AIDS is an acronym for “Acquired Immune Deficiency Syndrome” and represents the advanced stage of HIV infection. This stage occurs when the immune system has been severely compromised, leaving the body vulnerable to serious opportunistic infections and certain cancers.

If left untreated, HIV can progress to AIDS, but with the antiretroviral therapies available today, this progression can be prevented in the vast majority of cases through early diagnosis and consistent treatment.

How can you tell if you have HIV?

HIV infection cannot be diagnosed based on symptoms alone, since they can be vague, nonspecific, or completely absent. Diagnosis relies exclusively on specific laboratory testing. Blood tests, such as fourth-generation combination tests, are the most sensitive option and can detect both antibodies against the virus and the p24 antigen as early as 2 to 4 weeks after exposure. Saliva-based tests are a less invasive alternative but only detect antibodies and may require a longer window period to provide an accurate result.

How long after exposure do HIV symptoms appear?

Some people infected with HIV develop a set of generic symptoms, known as acute retroviral syndrome, approximately 2 to 4 weeks after infection. These symptoms, which can include fever, sore throat, skin rash, muscle aches, and swollen lymph nodes, are temporary and tend to resolve on their own within a few days to a few weeks. However, many people remain completely asymptomatic during this initial phase. The more severe symptoms associated with AIDS typically only appear after 5 to 10 years or more without treatment. During this advanced stage, the immune system is severely compromised, leaving the body vulnerable to opportunistic infections and other serious complications.

Where did HIV come from?

HIV is believed to have originated as a variant of Simian Immunodeficiency Virus (SIV), which naturally infects chimpanzees and other African primates. Scientists believe the virus crossed from animals to humans through a process called zoonosis, most likely occurring when hunters were exposed to infected blood while hunting and butchering primates for meat, sometime in the early twentieth century in Central Africa.

Can HIV be detected through routine blood tests?

No, HIV cannot be diagnosed through routine, general blood tests. Specific tests are required, such as those that detect antibodies, antigens, or viral RNA directly. If you have any concerns or have had a potentially risky exposure, it is important to consult a doctor for targeted testing. Routine blood tests, such as a complete blood count, are not designed to diagnose HIV, although in advanced stages of infection they may occasionally show some indirect, nonspecific signs, such as:

A reduction in white blood cells (leukopenia), reflecting general immune suppression, or enlarged lymph nodes and other immune system abnormalities, which are typically identified through physical examination rather than blood work alone.

These findings are not specific to HIV and would always require dedicated HIV testing to reach a definitive diagnosis.

How is HIV transmitted?

HIV is transmitted through direct contact with blood, semen, vaginal secretions, or breast milk from a person living with the virus. For transmission to occur, these fluids must come into contact with the bloodstream or mucous membranes of another person, for example through unprotected sexual intercourse, sharing needles, or from mother to child during pregnancy, childbirth, or breastfeeding. HIV is not transmitted through everyday contact such as hugging, shaking hands, or sharing household objects.

Can a person with HIV have HIV-negative children?

Yes. With appropriate medical guidance, effective antiretroviral therapy, and careful monitoring throughout pregnancy, delivery, and (when applicable) infant feeding, the risk of a mother transmitting HIV to her baby can be reduced to less than 1%. Couples in which one or both partners are HIV-positive can also explore options such as sperm washing or PrEP for the HIV-negative partner to further minimize transmission risk during conception.

Is it safe to kiss someone who is HIV-positive?

Yes, casual and even deep kissing carries essentially no risk of HIV transmission, since saliva does not contain significant amounts of the virus. The only theoretical risk would involve the presence of visible blood in the mouth of one partner, for example from active gum disease or an open wound, which is an extremely rare scenario in practice.

HIV and AIDS: Symptoms, Causes, Testing, and Transmission